Beyond PD-1/PD-L1: TME-Targeted Therapies in the Era of Immunotherapy Resistance. Journal of Biomolecules, Pathogenesis and Therapeutics, [S. l.], v. 2, n. 1, 2026. Disponível em: https://jbptjournal.org/index.php/jbpt/article/view/33. Acesso em: 10 apr. 2026.